Hepatitis C virus core protein transforms murine fibroblasts by promoting genomic instability

Cellular Oncology

Volumn 28, Issue 4, 2006, Pages 177-190

  Smirnova, Irina S ^a   Aksenov, Nikolai D ^a   Kashuba, Elena V ^c   Payakurel, Pawan ^c   Grabovetsky, Vadim V ^d,e   Zaberezhny, Alexei D ^d,e   Vonsky, Maxim S ^a   Buchinska, Lubov ^f   Biberfeld, Peter ^c   Hinkula, Jorma ^b,c   Isaguliants, Maria G ^b,d  

^a INSTITUTE OF CYTOLOGY   (Russian Federation)

^b SWEDISH INSTITUTE FOR INFECTIOUS DISEASE CONTROL   (Sweden)

^c KAROLINSKA INSTITUTE   (Sweden)

^d D I IVANOVSKY INSTITUTE OF VIROLOGY   (Russian Federation)

^e Narvac R and D Company   (Russian Federation)

^f R E KAVETSKY INSTITUTE OF EXPERIMENTAL PATHOLOGY   (Ukraine)

Author keywords

Constitutive expression; Core protein; Fibroblast; Fibrosarcoma; Genomic instability; Hepatitis C virus; Malignant transformation; Mitotic spindle cell checkpoint; p53

Indexed keywords

CORE PROTEIN;

ANCHORAGE INDEPENDENT GROWTH; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CANCER CELL; CANCER GROWTH; CANCER SUSCEPTIBILITY; CARCINOGENICITY; CELL IMMORTALIZATION; CELL MUTANT; CELL STRAIN 3T3; CONTACT INHIBITION; CONTROLLED STUDY; FEMALE; GENOMIC INSTABILITY; HEPATITIS C VIRUS; HOST SUSCEPTIBILITY; MALIGNANT TRANSFORMATION; MITOSIS SPINDLE; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PLOIDY; PRECANCER; PRIORITY JOURNAL; PROTEIN EXPRESSION; SCID MOUSE; TRANSACTIVATION; VIRUS CARCINOGENESIS;

ANIMALS; CELL CYCLE; CELL TRANSFORMATION, VIRAL; DNA FRAGMENTATION; FEMALE; FIBROBLASTS; GENES, REPORTER; GENOMIC INSTABILITY; MICE; MICE, SCID; MITOTIC SPINDLE APPARATUS; MOLECULAR SEQUENCE DATA; NIH 3T3 CELLS; VIRAL CORE PROTEINS;

EID: 33748910608     PISSN: 15705870     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (65)

1. H. Aoki, J. Hayashi, M. Moriyama, Y. Arakawa and O. Hino, Hepatitis C virus core protein interacts with 14-3-3 protein and activates the kinase Raf-1, J. Virol. 74 (2000), 1736-1741.
2. G.C. Bosma, R.P. Custer and M.J. Bosma, A severe combined immunodeficiency mutation in the mouse, Nature 301 (1983), 527-530.
3. Y. Cao, T. Hamada, T. Matsui, T. Date and K. Iwabuchi, Hepatitis C virus core protein interacts with p53-binding protein, 53BP2/Bbp/ASPP2, and inhibits p53-mediated apoptosis, Biochem. Biophys. Res. Commun. 315 (2004), 788-795.
4. J. Chang, S.H. Yang, Y.G. Cho, S.B. Hwang, Y.S. Hahn and Y.C. Sung, Hepatitis C virus core from two different genotypes has an oncogenic potential but is not sufficient for transforming primary rat embryo fibroblasts in cooperation with the H-ras oncogene, J. Virol. 72 (1998), 3060-3065.
5. N. Chikatsu, Y. Nakamura, H. Sato, T. Fujita, S. Asano, and T. Motokura, p53 mutations and tetraploids under r- and K-selection, Oncogene 21 (2002), 3043-3049.
6. J.W. Cho, W. Baek, S.I. Suh, S. Yang, J. Chang, Y.C. Sung and M.H. Suh, Hepatitis C virus core protein promotes cell proliferation through the upregulation of cyclin E expression levels, Liver 21 (2001), 137-142.
7. J.W. Cho, W. Baek, S. Yang, J. Chang, Y.C. Sung and M.H. Suh, HCV core protein modulates Rb pathway through pRb down-regulation and E2F-1 up-regulation, Biochim. Biophys. Acta 1538 (2001), 59-66.
8. Y.M. Chung, K.J. Park, S.Y. Choi, S.B. Hwang and S.Y. Lee, Hepatitis C virus core protein potentiates TNF-alpha-induced NF-kappaB activation through TRAF2-IKKbeta-dependent pathway, Biochem. Biophys. Res. Commun. 284 (2001), 15-19.
9. N. Delhem, A. Sabile, R. Gajardo, P. Podevin, A. Abadie, M.A. Blaton, D. Kremsdorf, L. Beretta and C. Brechot, Activation of the interferon-inducible protein kinase PKR by hepatocellular carcinoma derived-hepatitis C virus core protein, Oncogene 20 (2001), 5836-5845.
10. J. Dou, P. Liu and X. Zhang, Cellular response to gene expression profiles of different hepatitis C virus core proteins in the Huh-7 cell line with microarray analysis, J. Nanosci. Nanotechnol. 5 (2005), 1230-1235.
11. W.S. el-Deiry, T. Tokino, V.E. Velculescu, D.B. Levy, R. Parsons, J.M. Trent, D. Lin, W.E. Mercer, K.W. Kinzler and B. Vogelstein, WAF1, a potential mediator of p53 tumor suppression, Cell 75 (1993), 817-825.
12. A.M. Engel, I.M. Svane, J. Rygaard and O. Werdelin, MCA sarcomas induced in scid mice are more immunogenic than MCA sarcomas induced in congenic, immunocompetent mice, Scand. J. Immunol. 45 (1997), 463-470.
13. D. Hanahan and R.A. Weinberg, The hallmarks of cancer, Cell 100 (2000), 57-70.
14. J.H. Hoofnagle, Course and outcome of hepatitis C, Hepatology 36 (2002), S21-29.
15. C. Horie, H. Iwahana, T. Horie, I. Shimizu, K. Yoshimoto, S. Yogita, S. Tashiro, S. Ito and M. Itakura, Detection of different quasispecies of hepatitis C virus core region in cancerous and noncancerous lesions, Biochem. Biophys. Res. Commun. 218 (1996), 674-681.
16. T.S. Huang, M.L. Kuo, J.Y. Shew, Y.W. Chou and W.K. Yang, Distinct p53-mediated G1/S checkpoint responses in two NIH3T3 subclone cells following treatment with DNA-damaging agents, Oncogene 13 (1996), 625-632.
17. R. Idilman, N. De Maria, A. Colantoni and D.H. Van Thiel, Pathogenesis of hepatitis B and C-induced hepatocellular carcinoma, J. Viral Hepat. 5 (1998), 285-299.
18. M.G. Isaguliants, N.V. Petrakova, E.V. Kashuba, Y.G. Suzdaltzeva, S.V. Belikov, V.V. Mokhonov, A.G. Prilipov, L. Matskova, I.S. Smirnova, C. Jolivet-Reynaud and E. Nordenfelt, Immunization with hepatitis C virus core gene triggers potent T-cell response, but affects CD4+ T-cells, Vaccine 22 (2004), 1656-1665.
19. M.G. Isaguliants, N.V. Petrakova, V.V. Mokhonov, K. Pokrovskaya, Y.G. Suzdaltzeva, A.V. Krivonos, A.D. Zaberezhny, M.M. Garaev, V.D. Smirnov and E. Nordenfelt, DNA immunization efficiently targets conserved functional domains of protease and ATPase/helicase of nonstructural 3 protein (NS3), of human hepatitis C virus, Immunol. Lett. 88 (2003), 1-13.
20. T. Ishikawa, K. Shibuya, K. Yasui, K. Mitamura and S. Ueda, Expression of hepatitis C virus core protein associated with malignant lymphoma in transgenic mice, Comp. Immunol. Microbiol. Infect. Dis. 26 (2003), 115-124.
21. D.Y. Jin, H.L. Wang, Y. Zhou, A.C. Chun, K.V. Kibler, Y.D. Hou, H. Kung and K.T. Jeang, Hepatitis C virus core protein-induced loss of LZIP function correlates with cellular transformation, EMBO J. 19 (2000), 729-740.
22. M. Joo, Y.S. Hahn, M. Kwon, R.T. Sadikot, T.S. Blackwell and J.W. Christman, Hepatitis C virus core protein suppresses NF-κB activation and cyclooxygenase-2 expression by direct interaction with IκB kinase beta, J. Virol. 79 (2005), 7648-7657.
23. C.F. Kao, S.Y. Chen, J.Y. Chen and Y.H. Wu Lee, Modulation of p53 transcription regulatory activity and post-translational modification by hepatitis C virus core protein, Oncogene 23 (2004), 2472-2483.
24. N. Kato, H. Yoshida, S. Kioko Ono-Nita, J. Kato, T. Goto, M. Otsuka, K. Lan, K. Matsushima, Y. Shiratori and M. Omata, Activation of intracellular signaling by hepatitis B and C viruses: C-viral core is the most potent signal inducer, Hepatology 32 (2000), 405-412.
25. E. Katz and B.J. Carter, A mutant cell line derived from NIH/3T3 cells: two oncogenes required for in vitro transformation, J. Natl. Cancer Inst. 77 (1986), 909-914.
26. N. Keshava, Tumorigenicity of morphologically distinct transformed foci induced by 3-methylcholanthrene in BALB/c-3T3 cells, Mutat. Res. 447 (2000), 281-286.
27. K. Koike, K. Moriya and S. Kimura, Role of hepatitis C virus in the development of hepatocellular carcinoma: transgenic approach to viral hepatocarcinogenesis, J. Gastroenterol. Hepatol. 17 (2002), 394-400.
28. J. Kountouras, C. Zavos and D. Chatzopoulos, Apoptosis in hepatitis C, J. Viral Hepat. 10 (2003), 335-342.
29. H.J. Kwun and K.L. Jang, Dual effects of hepatitis C virus Core protein on the transcription of cyclin-dependent kinase inhibitor p21 gene, J. Viral Hepat. 10 (2003), 249-255.
30. S. Laconi, P. Pani, S. Pillai, D. Pasciu, D.S. Sarma and E. Laconi, A growth-constrained environment drives tumor progression in vivo, Proc. Natl. Acad. Sci. USA 98 (2001), 7806-7811.
31. K. Li, T. Prow, S.M. Lemon and M.R. Beard, Cellular response to conditional expression of hepatitis C virus core protein in Huh7 cultured human hepatoma cells, Hepatology 35 (2002), 1237-12346.
32. Q. Liu, C. Tackney, R.A. Bhat, A.M. Prince and P. Zhang, Regulated processing of hepatitis C virus core protein is linked to subcellular localization, J. Virol. 71 (1997), 657-662.
33. W. Lu, S.Y. Lo, M. Chen, K. Wu, Y.K. Fung and J.H. Ou, Activation of p53 tumor suppressor by hepatitis C virus core protein, Virology 264 (1999), 134-141.
34. S.E. Mamaeva, Karyotypic evolution of cells in culture: a new concept, Int. Rev. Cytol. 178 (1998), 1-40.
35. J.O. Manilay and M. Sykes, Natural killer cells and their role in graft rejection, Curr. Opin. Immunol. 10 (1998), 532-538.
36. H. Marusawa, M. Hijikata, T. Chiba and K. Shimotohno, Hepatitis C virus core protein inhibits Fas- and tumor necrosis factor alpha-mediated apoptosis via NF-κB activation, J. Virol. 73 (1999), 4713-4720.
37. K. Moriya, K. Nakagawa, T. Santa, Y. Shintani, H. Fujie, H. Miyoshi, T. Tsutsumi, T. Miyazawa, K. Ishibashi, T. Horie, K. Imai, T. Todoroki, S. Kimura and K. Koike, Oxidative stress in the absence of inflammation in a mouse model for hepatitis C virus-associated hepatocarcinogenesis, Cancer Res. 61 (2001), 4365-4370.
38. T. Naas, M. Ghorbani, I. Alvarez-Maya, M. Lapner, R. Kothary, Y. De Repentigny, S. Gomes, L. Babiuk, A. Giulivi, C. Soare, A. Azizi and F. Diaz-Mitoma, Characterization of liver histopathology in a transgenic mouse model expressing genotype 1a hepatitis C virus core and envelope proteins 1 and 2, J. Gen. Virol. 86 (2005), 2185-2196.
39. H. Nguyen, M. Mudryj, M. Guadalupe and S. Dandekar, Hepatitis C virus core protein expression leads to biphasic regulation of the p21 cdk inhibitor and modulation of hepatocyte cell cycle, Virology 312 (2003), 245-253.
40. S. Ogata, M. Nagano-Fujii, Y. Ku, S. Yoon and H. Hotta, Comparative sequence analysis of the core protein and its frameshift product, the F protein, of hepatitis C virus subtype 1b strains obtained from patients with and without hepatocellular carcinoma, J. Clin. Microbiol. 40 (2002), 3625-3630.
41. M. Okuda, K. Li, M.R. Beard, L.A. Showalter, F. Scholle, S.M. Lemon and S.A. Weinman, Mitochondrial injury, oxidative stress, and antioxidant gene expression are induced by hepatitis C virus core protein, Gastroenterology 122 (2002), 366-375.
42. M. Otsuka, N. Kato, K. Lan, H. Yoshida, J. Kato, T. Goto, Y. Shiratori and M. Omata, Hepatitis C virus core protein enhances p53 function through augmentation of DNA binding affinity and transcriptional ability, J. Biol. Chem. 275 (2000), 34122-34130.
43. W. Qian, E. Kashuba, K.P. Magnusson, K. Pokrovskaja, I. Okan, G. Klein and K.G. Wiman, Role of p53 mutation in polyomavirus-induced tumorigenesis, J. Gen. Virol. 78 (1997), 893-903.
44. R.B. Ray, L.M. Lagging, K. Meyer, R. Steele and R. Ray, Transcriptional regulation of cellular and viral promoters by the hepatitis C virus core protein, Virus Res. 37 (1995), 209-220.
45. R.B. Ray, K. Meyer, R. Steele, A. Shrivastava, B.B. Aggarwal and R. Ray, Inhibition of tumor necrosis factor (TNF-alpha)-mediated apoptosis by hepatitis C virus core protein, J. Biol. Chem. 273 (1998), 2256-2259.
46. R.B. Ray and R. Ray, Hepatitis C virus core protein: intriguing properties and functional relevance, FEMS Microbiol. Lett. 202 (2001), 149-156.
47. R.B. Ray, R. Steele, A. Basu, K. Meyer, M. Majumder, A.K. Ghosh and R. Ray, Distinct functional role of hepatitis C virus core protein on NF-κB regulation is linked to genomic variation, Virus Res. 87 (2002), 21-29.
48. S. Realdon, M. Gerotto, F. Dal Pero, O. Marin, A. Granato, G. Basso, M. Muraca and A. Alberti, Proapoptotic effect of hepatitis C virus CORE protein in transiently transfected cells is enhanced by nuclear localization and is dependent on PKR activation, J. Hepatol. 40 (2004), 77-85.
49. M.E. Reeves and R.P. DeMatteo, Genes and viruses in hepatobiliary neoplasia, Semin. Surg. Oncol. 19 (2000), 84-93.
50. M.A. Resnick and A. Inga, Functional mutants of the sequence-specific transcription factor p53 and implications for master genes of diversity, Proc. Natl. Acad. Sci. USA 100 (2003), 9934-9939.
51. B. Ruster, S. Zeuzem, V. Krump-Konvalinkova, T. Berg, S. Jonas, K. Severin and W.K. Roth, Comparative sequence analysis of the core- and NS5-region of hepatitis C virus from tumor and adjacent non-tumor tissue, J. Med. Virol. 63 (2001), 128-134.
52. D. Sakamuro, T. Furukawa and T. Takegami, Hepatitis C virus nonstructural protein NS3 transforms NIH 3T3 cells, J. Virol. 69 (1995), 3893-3896.
53. Y. Shan, X.G. Chen, B. Huang, A.B. Hu, D. Xiao and Z.M. Guo, Malignant transformation of the cultured human hepatocytes induced by hepatitis C virus core protein, Liver Int. 25 (2005), 141-147.
54. A. Shrivastava, S.K. Manna, R. Ray and B.B. Aggarwal, Ectopic expression of hepatitis C virus core protein differentially regulates nuclear transcription factors, J. Virol. 72 (1998), 9722-9728.
55. S. Siavoshian, J.D. Abraham, M.P. Kieny and C. Schuster, HCV core, NS3, NS5A and NS5B proteins modulate cell proliferation independently from p53 expression in hepatocarcinoma cell lines, Arch. Virol. 149 (2004), 323-336.
56. M. Takamatsu, T. Fujita and H. Hotta, Suppression of serum starvation-induced apoptosis by hepatitis C virus core protein, Kobe J. Med. Sci. 47 (2001), 97-112.
57. Y. Takihara, Y. Matsuda and J. Hara, Role of the beta isoform of 14-3-3 proteins in cellular proliferation and oncogenic transformation, Carcinogenesis 21 (2000), 2073-2077.
58. T.L. Tellinghuisen and C.M. Rice, Interaction between hepatitis C virus proteins and host cell factors, Curr. Opin. Microbiol. 5 (2002), 419-427.
59. K. Tsuchihara, M. Hijikata, K. Fukuda, T. Kuroki, N. Yamamoto and K. Shimotohno, Hepatitis C virus core protein regulates cell growth and signal transduction pathway transmitting growth stimuli, Virology 258 (1999), 100-107.
60. B. Vogelstein, D. Lane and A.J. Levine, Surfing the p53 network, Nature 408 (2000), 307-310.
61. R. Wadhwa, S. Takano, M. Robert, A. Yoshida, H. Nomura, R.R. Reddel, Y. Mitsui and S.C. Kaul, Inactivation of tumor suppressor p53 by mot-2, a hsp70 family member, J. Biol. Chem. 273 (1998), 29586-29591.
62. T. Yamanaka, M. Uchida and T. Doi, Innate form of HCV core protein plays an important role in the localization and the function of HCV core protein, Biochem. Biophys. Res. Commun. 294 (2002), 521-527.
63. H. Yoshida, N. Kato, Y. Shiratori, M. Otsuka, S. Maeda, J. Kato and M. Omata, Hepatitis C virus core protein activates nuclear factor kappa B-dependent signaling through tumor necrosis factor receptor-associated factor, J. Biol. Chem. 276 (2001), 16399-16405.
64. T. Yoshida, T. Hanada, T. Tokuhisa, K. Kosai, M. Sata, M. Kohara and A. Yoshimur, Activation of STAT3 by the hepatitis C virus core protein leads to cellular transformation, J. Exp. Med. 196 (2002), 641-653.
65. Y.S. Yu, X.S. Sun, H.N. Jiang, Y. Han, C.B. Zhao and J.H. Tan, Studies of the cell cycle of in vitro cultured skin fibroblasts in goats: work in progres, Theriogenology 59 (2003), 1277-1289.